"c14" Pill Images
The following drug pill images match your search criteria.
1 / 2
Loading
C L 409
Metoprolol Succinate Extended-Release
- Strength
- 200 mg
- Imprint
- C L 409
- Color
- White
- Shape
- Capsule/Oblong
1 / 2
Loading
CL 410
![Pill CL 4 White Oval is Pramipexole Dihydrochloride](https://www.drugs.com/images/pills/nlm/33342-0033-10_NLMIMAGE10_C445E22F.jpg)
1 / 2
Loading
CL 4
![Pill APO CI 40 White Oval is Citalopram Hydrobromide](https://www.drugs.com/images/pills/nlm/605052520.jpg)
1 / 4
Loading
APO CI 40
1 / 2
Loading
CL 412
1 / 2
Loading
CL 411
CL49 100 mg
Minocycline Hydrochloride
- Strength
- 100 mg
- Imprint
- CL49 100 mg
- Color
- Gray / White
- Shape
- Capsule/Oblong
CL47 50 mg
Minocycline Hydrochloride
- Strength
- 50 mg
- Imprint
- CL47 50 mg
- Color
- White
- Shape
- Capsule/Oblong
1 / 2
Loading
SCI 4
Sodium Fluoride (Chewable)
- Strength
- 2.2 mg (equiv. fluoride 1 mg)
- Imprint
- SCI 4
- Color
- White
- Shape
- Round
CL48 75 mg
Minocycline Hydrochloride
- Strength
- 75 mg
- Imprint
- CL48 75 mg
- Color
- Gray
- Shape
- Capsule/Oblong
![Pill CL 403 Yellow Capsule/Oblong is Nevirapine Extended-Release](https://www.drugs.com/images/pills/custom/pill24355-1/nevirapine-extended-release.jpeg)
CL 403
Nevirapine Extended-Release
- Strength
- 400 mg
- Imprint
- CL 403
- Color
- Yellow
- Shape
- Capsule/Oblong
DCI 4
Pertzye
- Strength
- amylase 15,125 USP units; lipase 4,000 USP units; protease 14,375 USP units
- Imprint
- DCI 4
- Color
- Clear & Green
- Shape
- Capsule/Oblong
![Pill SCI 4 White Round is Ludent](https://www.drugs.com/images/pills/nlm/449461010.jpg)
SCI 4
Ludent
- Strength
- sodium fluoride 2.2 mg (equiv. fluoride 1 mg)
- Imprint
- SCI 4
- Color
- White
- Shape
- Round
![Pill CL 48 Red & White Capsule/Oblong is Hydrochlorothiazide and Telmisartan](/img/pillid/no-image-placeholder.png)
CL 48
Hydrochlorothiazide and Telmisartan
- Strength
- 12.5 mg / 40 mg
- Imprint
- CL 48
- Color
- Red & White
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.